Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.

SCHAFFHAUSEN, Switzerland, Aug. 16, 2021 -- (Healthcare Sales & Marketing Network) -- Occlutech Holding AG ("Occlutech"), one of the world´s leading providers of minimally invasive structural heart disease devices, announces the conditiona... Devices, Interventional, Cardiology, FDA Occlutech, Flex II, PFO Occluder
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news